EOM Pharmaceuticals Holdings, Inc.
EOM Pharmaceuticals Holdings, Inc. (IMUC) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0000822411 · IMUC · OTC · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0000822411 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
EOM Pharmaceuticals Holdings, Inc. (OTC: IMUC) has submitted 558 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Healthcare sector company with CIK 0000822411, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is EOM Pharmaceuticals Holdings, Inc.'s most comprehensive regulatory disclosure. The most recent EOM Pharmaceuticals Holdings, Inc. 10-K was filed on 2018-03-14 for fiscal year ending 2018. Historical IMUC 10-K annual reports are available from 1999 through 2018.
Investors researching EOM Pharmaceuticals Holdings, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
IMUC SEC Filings · 8 questionsEOM Pharmaceuticals Holdings, Inc. (IMUC) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 558 filings and access original documents at no cost. EOM Pharmaceuticals Holdings, Inc.'s CIK is 0000822411.